Using Local Laboratory Data in Phase II and III Pivotal Studies

is being presented by Jaap H.M. Dijkman, CEO, of Medial NL and airs on Thursday, September 23rd, 2010. For more details or to register please visit our site at www.fxconferences.com

Many pivotal studies rely on local laboratory data for their endpoints, either as standalone lab data or in conjunction with central laboratory data. But what limitations do local laboratory data have in terms of quality and variability? And how easy or difficult is it to collect them? This audio conference presentation provides comparisons between central and local laboratory data in terms of quality and combinability, and gives attendees valuable insight into choosing the right design for their clinical trials.